Related content

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

By Petrakis Ismene   O’Malley Stephanie   Rounsaville Bruce   Poling James   McHugh-Strong Colette   Krystal John  

Psychopharmacology, Vol. 172, Iss. 3, 2004-03 ,pp. : 291-297

Springer Publishing Company

Access to resources Recommend Favorite

Patient and Provider Attitudes towards Monitored Naltrexone Treatment of Alcohol Dependence in Schizophrenia

By Leontieva Luba   Dimmock Jacqueline   Cavallerano Michelle   DeRycke Sara   Meszaros Zsuzsa   Carey Kate   Ploutz-Snyder Robert   Batki Steven  

The American Journal of Drug and Alcohol Abuse, Vol. 35, Iss. 5, 2009-09 ,pp. : 273-278

Informa Healthcare

Access to resources Recommend Favorite

A mu opioid receptor gene polymorphism (A118G) and naltrexone treatment response in adherent Korean alcohol-dependent patients

By Kim Sung-Gon  

Psychopharmacology, Vol. 201, Iss. 4, 2009-01 ,pp. : 611-618

Springer Publishing Company

Access to resources Recommend Favorite

Naltrexone Versus Acamprosate: One Year Follow-Up Of Alcohol Dependence Treatment

By Rubio G.   Jimnez-Arriero M. A.   Ponce G.   Palomo T.  

Alcohol and Alcoholism, Vol. 47, Iss. 6, 2012-11 ,pp. : 744-744

Oxford University Press

Access to resources Recommend Favorite

Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment

By Mason B.J.  

European Neuropsychopharmacology, Vol. 13, Iss. 6, 2003-12 ,pp. : 469-475

Elsevier

Access to resources Recommend Favorite